Forbius competitorsClear all

Forbius's top competitors include Agios Pharmaceuticals and CytomX Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Forbius
Forbius
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Founding Date
Founding Date
2011
Founding Date
2008
Founding Date
2008
Type
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Montréal, CA
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
13
Employees
53611% increase
Employees
15815% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.2 b
Valuation ($)
124 m
Twitter followers
Twitter followers
98
Twitter followers
2.4 k
Twitter followers
970
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
3
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
617754
Alexa Website Rank
524109
Employee Rating
Employee Rating
2.8
Employee Rating
4.1
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$203.2m (FY, 2020)
Revenue (est.)
$100.4m (FY, 2020)
Net income
Net income
N/A
Net income
($327.4m) (FY, 2020)
Net income
($32.9m) (FY, 2020)
For sources of this data, please see the company profile

View company profiles

Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company